OPTN/SRTR 2016 Annual Data Report: Economics
OPTN/SRTR 2016 Annual Data Report: Economics
复制标题
DOI：
10.1111/ajt.14564
复制
发表时间：
2018-01-01
影响因子：
8.8
通讯作者：
Kasiske, B. L.
中科院分区：
文献类型：
--
作者：
Schnitzler, M. A.;Skeans, M. A.;Kasiske, B. L.
实体器官移植受者的医疗保险费用因结果而异：移植物功能存活、移植失败存活和死亡。对于移植后第一年幸存并具有功能性移植物的肾脏接受者，每人每年平均报销为 7.5 万美元；对于需要返回透析或重新移植的人，每人每年平均报销 17.1 万美元；对于死亡但仍具有功能的人，人均每年报销 35 万美元。对于胰腺受者来说：移植后第一年幸存的患者可获得 10.5 万美元，胰腺衰竭后幸存的患者可获得 12 万美元，死亡后仍具有功能的患者可获得 44.3 万美元。对于肝脏接受者：移植功能正常的存活者为 15.4 万美元，需要再次移植的患者为 38.8 万美元，死亡时功能正常的患者为 74 万美元。对于肠道接受者：那些存活且具有功能性移植物的患者可获得 30.1 万美元，而那些具有功能性死亡的患者则可获得 100 万美元。对于心脏受者来说：27.2万美元用于那些移植功能正常的存活者，120万美元用于那些功能正常死亡的人。对于肺移植受者：移植功能正常的存活者为 19.6 万美元，需要再次移植的患者为 64.2 万美元，而死亡时仍具有功能的患者为 76.1 万美元。
Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per-person per-year reimbursement was $75 thousand for kidney recipients who survived the first year posttransplant with a functioning graft, $171 thousand for those who required a return to dialysis or retransplant, and $350 thousand for those who died with function. For pancreas recipients: $105 thousand for those who survived the first year with a functioning graft, $120 thousand for those who survived pancreas failure, and $443 thousand for those who died with function. For liver recipients: $154 thousand for those who survived with a functioning graft, $388 thousand for those who required retransplant, and $740 thousand who died with function. For intestine recipients: $301 thousand for those who survived with a functioning graft and $1 million for those who died with function. For heart recipients: $272 thousand for those who survived with a functioning graft and $1.2 million for those who died with function. For lung recipients: $196 thousand for those who survived with a functioning graft, $642 thousand for those who required retransplant, and $761 thousand for those who died with function.